Manulife (Manufacturers Life Insurance)’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-130,077
Closed -$1.76M 2720
2018
Q4
$1.76M Sell
130,077
-511,147
-80% -$5.71M ﹤0.01% 1401
2018
Q3
$7.12M Buy
+641,224
New +$6.42M 0.01% 1077
2017
Q1
Sell
-1,053
Closed -$5K 4528
2016
Q4
$5K Hold
1,053
﹤0.01% 3962
2016
Q3
$5K Hold
1,053
﹤0.01% 3907
2016
Q2
$5K Sell
1,053
-12,876
-92% -$69.3K ﹤0.01% 3840
2016
Q1
$75K Buy
13,929
+576
+4% +$4.02K ﹤0.01% 3172
2015
Q4
$139 Buy
13,353
+244
+2% +$3.31K ﹤0.01% 2923
2015
Q3
$239 Buy
13,109
+226
+2% +$4.36K ﹤0.01% 2499
2015
Q2
$251 Sell
12,883
-796
-6% -$14.1K ﹤0.01% 2673
2015
Q1
$241 Buy
13,679
+506
+4% +$8.5K ﹤0.01% 2593
2014
Q4
$211 Buy
13,173
+469
+4% +$6.28K ﹤0.01% 2602
2014
Q3
$160 Sell
12,704
-467
-4% -$6.66K ﹤0.01% 2793
2014
Q2
$206K Sell
13,171
-361
-3% -$5.31K ﹤0.01% 2695
2014
Q1
$178 Buy
13,532
+1,039
+8% +$16.3K ﹤0.01% 2803
2013
Q4
$201 Sell
12,493
-1,488
-11% -$23.7K ﹤0.01% 2721
2013
Q3
$232 Sell
13,981
-487
-3% -$7.2K ﹤0.01% 2539
2013
Q2
$146K Buy
+14,468
New +$152K ﹤0.01% 2799

Other funds holding OSIR

Manulife (Manufacturers Life Insurance)'s OSIR Position: Q1 2019 in Review

Manulife (Manufacturers Life Insurance) sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2019, closing a stake of 130,077 shares — an estimated $1.76M sold.

Manulife (Manufacturers Life Insurance) first reported a position in OSIR in Q2 2013 and held it in 17 quarters. The position peaked at $7.12M in Q3 2018. 57 funds tracked by Wall St. Rank hold OSIR as of Q1 2019.

  • Manulife (Manufacturers Life Insurance) reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 130,077 Osiris Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $1.76M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
  • Manulife (Manufacturers Life Insurance)'s Osiris Therapeutics, Inc. Common Stock position peaked at $7.12M in Q3 2018.
  • 57 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2019, filed 13 May 2019.